Ajooni Biotech Limited Share Price & Company Info
- Market cap
- ₹52.38 Cras reported by NSE
- 52-week high
- ₹5.5009-FEB-2026
- 52-week low
- ₹2.6812-OCT-2026
- P/E (NSE)
- 13.14
- Face value
- ₹2.00
- Shares issued
- 18,12,43,598
- Volume
- 4,88,487₹0.16 Cr traded
- Delivery
- 57.05%of traded quantity
- Price band
- 20%₹2.30 – ₹3.44 on 2026-10-28
- Annual volatility
- 51.58%NSE, from daily returns
- Series
- EQrolling settlement
- ISIN
- INE820Y01021
- Listed on NSE
- 07-May-2021
About Ajooni Biotech Limited
Ajooni Biotech Limited is listed on the National Stock Exchange of India under the symbol AJOONI in the EQ series. NSE classifies it under the basic industry Animal Feed, part of the Fast Moving Consumer Goods sector. Its shares were listed on NSE on 07-May-2021. Each share has a face value of ₹2.00.
In the end-of-day data for 16 November 2026 the stock closed at ₹3.07, down 1.92% on the day. NSE puts the company's market capitalisation at about ₹52.38 crore, which puts it among the smallest listed companies in India. Over the past 52 weeks it has traded between ₹2.68 and ₹5.50, so the last price is 14.6% above the low and 44.2% below the high.
4,88,487 shares changed hands that day, and 57.05% of them were taken as delivery rather than squared off intraday. A high delivery share means most of the day's buyers chose to hold the shares; a low one usually means the volume was mostly short-term trading.
EQ is the normal equity series: shares settle on the usual T+1 cycle and intraday trading is allowed.
NSE puts the stock's annualised volatility at 51.58%. That is well above the level of large, established companies, so double-digit swings within a month are common.
Because the share trades below ₹5, it also appears in our list of penny stocks under ₹5, which explains the extra risks that come with low-priced shares.
Ajooni Biotech Limited quarterly results
In the quarter ended June 2026 (un-audited), Ajooni Biotech Limited reported total income of ₹63.76 crore and a net profit of ₹0.43 crore, or ₹0.01 per share. That is a net margin of 0.7% on income.
A year earlier, in the June 2025 quarter, income was ₹31.91 crore with a net profit of ₹0.78 crore. Income has grown 99.8% year on year. Net profit has fallen 44.9%.
Ajooni Biotech Limited was profitable in 5 of the 5 quarters shown below, every one of them. Figures are as filed with NSE, in ₹ crore.
| Quarter ended | Total income | Profit before tax | Net profit | EPS | Status |
|---|---|---|---|---|---|
| June 2026 | 63.76 | 0.65 | 0.43 | 0.01 | Un-Audited |
| March 2026 | 61.93 | 1.12 | 0.95 | 0.05 | Audited |
| December 2025 | 59.07 | 2.36 | 1.65 | 0.10 | Un-Audited |
| September 2025 | 31.88 | 1.23 | 0.93 | 0.08 | Un-Audited |
| June 2025 | 31.91 | 1.03 | 0.78 | 0.02 | Un-Audited |
Ajooni Biotech Limited shareholding pattern
At the end of September 2026, promoters and the promoter group held 30.53% of Ajooni Biotech Limited, with the public holding 69.47%. That is up 3.64 percentage points from 26.89% in March 2025.
| Quarter ended | Promoter & Promoter Group (%) | Public (%) |
|---|---|---|
| September 2026 | 30.53 | 69.47 |
| August 2026 | 30.53 | 69.47 |
| June 2026 | 26.89 | 73.11 |
| March 2026 | 26.89 | 73.11 |
| December 2025 | 26.89 | 73.11 |
| September 2025 | 26.89 | 73.11 |
| June 2025 | 26.89 | 73.11 |
| March 2025 | 26.89 | 73.11 |
Ajooni Biotech Limited share price performance
Over the past year the Ajooni Biotech Limited share price has lost 43.69%, against a fall of 12.39% for the NIFTY 50, so it has underperformed that index by 31.30 percentage points.
Across the 7 periods in the table, the stock did not beat the NIFTY 50 in any of them. Past returns describe what happened; they do not predict what comes next.
| Period | AJOONI | NIFTY 50 |
|---|---|---|
| 1 month | -9.09% | -1.69% |
| 3 months | -26.95% | -5.19% |
| 6 months | -30.79% | -5.57% |
| 1 year | -43.69% | -12.39% |
| 2 years | -58.75% | -5.92% |
| 3 years | -24.08% | +19.44% |
| 5 years | -70.41% | +24.92% |
Ajooni Biotech Limited vs industry peers
NSE compares Ajooni Biotech Limited with 5 other listed companies in Animal Feed. By market capitalisation it ranks 6 of 6, the smallest in the group.
Its P/E of 13.14 compares with a median of 19.45 for the other companies in the group.
| Company | Market cap | Price (₹) | P/E | Promoter % | Qtr income | Qtr net profit |
|---|---|---|---|---|---|---|
| GODREJAGRO | 11,227 | 583.50 | 26.41 | 67.74 | 2,269 | 184 |
| AVANTIFEED | 9,169 | 673.00 | 15.29 | 43.23 | 1,615 | 84.23 |
| MUKKA | 747 | 24.90 | 9.96 | 73.33 | 408 | 19.41 |
| WATERBASE | 170 | 41.00 | — | 0.00 | — | — |
| NARMADA | 87.33 | 11.51 | 23.61 | 50.30 | 22.55 | 0.75 |
| AJOONI | 52.56 | 2.90 | 13.14 | 26.89 | 63.76 | 0.43 |
Ajooni Biotech Limited announcements, board meetings and corporate actions
Latest announcements
The most recent filings Ajooni Biotech Limited has made with NSE, newest first:
- 19-Oct-2026 · Updates: Ajooni Biotech Limited has informed the Exchange regarding 'Undertaking of functional website'. (PDF)
- 15-Oct-2026 · Updates: Ajooni Biotech Limited has informed the Exchange regarding 'Confirmation Certificate as per Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the Quarter Ended on 30th June, 2026'. (PDF)
- 29-Sep-2026 · Trading Window: Ajooni Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (PDF)
- 14-Aug-2026 · Outcome of Board Meeting: Ajooni Biotech Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. (PDF)
- 14-Aug-2026 · Outcome of Board Meeting: Ajooni Biotech Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. (PDF)
- 12-Aug-2026 · Allotment of Securities: Ajooni Biotech Limited has informed the Exchange regarding allotment of 9000000 securities pursuant to Preferential Issue at its meeting held on August 12, 2026 (PDF)
- 31-Jul-2026 · Amendment to AOA/MOA: Ajooni Biotech Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company. (PDF)
- 31-Jul-2026 · Increase in Authorised Capital: Ajooni Biotech Limited has informed the Exchange about increase in Authorised Capital (PDF)
Board meetings
- 14-Aug-2026 · Financial Results: To consider and approve the financial results for the period ended Jun 30, 2026
- 29-Jun-2026 · Fund Raising/Other business matters: To consider Fund Raising and other business matters
- 28-May-2026 · Financial Results: To consider and approve the financial results for the period ended March 31, 2026
- 30-Jan-2026 · Financial Results/Other business matters: To consider and approve the financial results for the period ended December 31, 2025 and other business matters
- 13-Nov-2025 · Financial Results: To consider and approve the financial results for the period ended September 30, 2025
Corporate actions
The corporate actions on record include 1 share split, 2 rights issues. The ex-date is the first day the shares trade without the entitlement.
- Annual General Meeting · ex-date 10-Sep-2024 · book closure 11-Sep-2024 to 17-Sep-2024
- Rights 1:1 @ Premium Rs 3/- · ex-date 07-May-2024 · record date 07-May-2024
- Annual General Meeting · ex-date 29-Aug-2023 · book closure 30-Aug-2023 to 05-Sep-2023
- Rights 29:30 @ Premium Rs 4/- · ex-date 25-Nov-2022 · record date 25-Nov-2022
- Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share · ex-date 07-Oct-2022 · record date 07-Oct-2022
- Annual General Meeting · ex-date 13-Sep-2022 · book closure 14-Sep-2022 to 20-Sep-2022
- Annual General Meeting · ex-date 17-Sep-2021 · book closure 21-Sep-2021 to 27-Sep-2021
Risk notice: low-priced and small-company shares can be illiquid, volatile and subject to manipulation, and shareholders can lose their entire investment. This page is a factual summary, not a recommendation to buy or sell Ajooni Biotech Limited.
Where to find Ajooni Biotech Limited's financials
Direct downloads from NSE:
- Annual report 2025-26 (PDF, 1.62 MB)
- Annual report 2024-25 (PDF, 2.37 MB)
- Annual report 2023-24 (PDF)
- Annual report 2022-23 (ZIP)
- Annual report 2021-22 (ZIP)
- Annual report 2020-21 (ZIP)
For full financial statements, shareholding detail and every company announcement, go to the source:
- NSE quote pageOfficial price, price band, surveillance status, shareholding pattern and corporate actions.
- Annual reports (NSE)Search “AJOONI” to download Ajooni Biotech Limited's annual reports as filed with the exchange.
- Announcements and results (NSE)Search “AJOONI” for quarterly results, board meetings and other company filings.
- ScreenerTen years of profit and loss, balance sheet, cash flow and key ratios.
- TradingView chartInteractive price chart with technical indicators.
- Google FinanceQuick price overview and recent news coverage.
- Yahoo FinanceHistorical prices you can download, plus summary statistics.
Other Animal Feed stocks on MCX Trends
- Mukka Proteins Limited (MUKKA · ₹25.70)
- Narmada Agrobase Limited (NARMADA · ₹11.63)
- Waterbase Limited (WATERBASE · ₹42.85)
- Kwality Wall's (India) Limited (KWIL · ₹42.86)
- HMA Agro Industries Limited (HMAAGRO · ₹26.09)
- Coastal Corporation Limited (COASTCORP · ₹33.38)
- Kohinoor Foods Limited (KOHINOOR · ₹27.60)
- Foods & Inns Limited (FOODSIN · ₹43.92)
Frequently asked questions
What is the Ajooni Biotech Limited share price?
Ajooni Biotech Limited (NSE: AJOONI) closed at ₹3.07 in the end-of-day data for 16 November 2026. For a live price, use the NSE quote page or your broker, because this page is updated from end-of-day files.
Which sector does Ajooni Biotech Limited belong to?
NSE classifies Ajooni Biotech Limited under Animal Feed, in the Fast Moving Consumer Goods sector.
What is the 52-week high and low of AJOONI?
The 52-week high is ₹5.50 (09-FEB-2026) and the 52-week low is ₹2.68 (12-OCT-2026), according to NSE.
Is Ajooni Biotech Limited a penny stock?
At ₹3.07 the share trades below ₹5, so it appears on our list of penny stocks under ₹5. A low share price on its own says nothing about whether a company is cheap or expensive; market capitalisation, debt, profits and exchange surveillance status matter far more.
What is the promoter holding in Ajooni Biotech Limited?
Promoters and the promoter group held 30.53% of Ajooni Biotech Limited at the end of September 2026, according to the shareholding pattern filed with NSE.
What were Ajooni Biotech Limited's latest quarterly results?
For the quarter ended June 2026, Ajooni Biotech Limited reported total income of ₹63.76 crore and a net profit of ₹0.43 crore (EPS ₹0.01).
Where can I find Ajooni Biotech Limited's annual report and financial results?
Annual reports, quarterly results and other filings are published on the NSE corporate filings pages (search for AJOONI). Screener also lays out several years of financial statements in one place. Links to all of these are above.